CD56 Is an Unfavorable Prognostic Factor for Acute Promyelocytic Leukemia: Results By Multivariate Analyses in the JALSG-APL204 Study

被引：0

作者：

Takeshita, Akihiro ^{[1
]}

Asou, Norio ^{[2
]}

Atsuta, Yoshiko ^{[3
]}

Furumaki, Hiroaki ^{[1
]}

Sakura, Toru ^{[4
]}

Ueda, Yasunori ^{[5
]}

Sawa, Masashi ^{[6
]}

Dobashi, Nobuaki ^{[7
]}

Suzuki, Rikio ^{[8
]}

Taniguchi, Yasuhiro ^{[9
]}

Nakagawa, Masaru ^{[10
]}

Tamaki, Shigehisa ^{[11
]}

Hagihara, Maki ^{[12
]}

Fujimaki, Katsumichi ^{[13
]}

Yokoyama, Yasuhisa ^{[14
]}

Fujita, Hiroyuki ^{[15
]}

Yanada, Masamitsu ^{[16
]}

Maeda, Yoshinobu ^{[17
]}

Usui, Noriko ^{[18
]}

Kobayashi, Yukio ^{[19
]}

Kiyoi, Hitoshi ^{[20
]}

Ohtake, Shigeki ^{[21
]}

Matsumura, Itaru ^{[9
]}

Naoe, Tomoki ^{[22
]}

Miyazaki, Yasushi ^{[23
]}

机构：

[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan

[2] Saitama Med Univ, Int Med Ctr, Hidaka, Saitama, Japan

[3] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan

[4] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Maebashi, Gunma, Japan

[5] Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan

[6] Anjo Kosei Hosp, Anjo, Japan

[7] Jikei Univ, Dept Clin Oncol & Hematol, Daisan Hosp, Tokyo, Japan

[8] Tokai Univ, Sch Med, Isahara, Japan

[9] Kindai Univ, Fac Med, Osaka, Japan

[10] Nihon Univ, Sch Med, Tokyo, Japan

[11] Ise Red Cross Hosp, Ise, Japan

[12] Yokohama City Univ, Dept Hematol, Med Ctr, Yokohama, Kanagawa, Japan

[13] Fujisawa City Hosp, Fujisawa, Kanagawa, Japan

[14] Univ Tsukuba, Dept Hematol, Fac Med, Tsukuba, Ibaraki, Japan

[15] Yokohama City Univ, Dept Hematol & Clin Immunol, Grad Sch Med, Yokohama, Kanagawa, Japan

[16] Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan

[17] Okayama Univ, Dept Hematol & Oncol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan

[18] Jikei Univ, Dept Internal Med, Div Clin Oncol & Hematol, Sch Med, Tokyo, Japan

[19] IUHW Mita Hosp, Div Hematol, Tokyo, Japan

[20] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan

[21] Kanazawa Univ, Kanazawa, Ishikawa, Japan

[22] Nagoya Med Ctr, Natl Hosp Org, Nagoya, Aichi, Japan

[23] Nagasaki Univ, Atom Bomb Dis Inst, Nagasaki, Japan

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-111638

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2798

引用

页数：3

共 50 条

[21] Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia
Djunic, Irena
Virijevic, Marijana
Djurasinovic, Vladislava
Novkovic, Aleksandra
Colovic, Natasa
Kraguljac-Kurtovic, Nada
Vidovic, Ana
Suvajdzic-Vukovic, Nada
Tomin, Dragica
MEDICAL ONCOLOGY, 2012, 29 (03) : 2077 - 2082
[22] Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia
Irena Djunic
Marijana Virijevic
Vladislava Djurasinovic
Aleksandra Novkovic
Natasa Colovic
Nada Kraguljac-Kurtovic
Ana Vidovic
Nada Suvajdzic-Vukovic
Dragica Tomin
Medical Oncology, 2012, 29 : 2077 - 2082
[23] A Phase III Study of New Synthetic Retinoid Tamibarotene(Am80) Compared with ATRA in Maintenance Therapy for Newly Diagnosed Acute Promyelocytic Leukemia (APL): Japan Adult Leukemia Study Group (JALSG) APL204 Study
Shinagawa, Katsuji
Ohtake, Shigeki
Sakura, Toru
Ueda, Yasunori
Sawa, Masashi
Miyatake, Jun-ichi
Usui, Noriko
Onitsuka, Makoto
Hatta, Yoshihiro
Emi, Nobuhiko
Tamaki, Shigehisa
Ito, Yoshikazu
Murayama, Toru
Fujita, Hiroyuki
Fujimaki, Katsumichi
Asou, Norio
Takeshita, Akihiro
Miyazaki, Yasushi
Miyawaki, Shuichi
Ohnishi, Kazunori
Naoe, Tomoki
Ohno, Ryuzo
BLOOD, 2012, 120 (21)
[24] Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis
Xu, Shuangnian
Li, Xi
Zhang, Jianmin
Chen, Jieping
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (10) : 1859 - 1870
[25] Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis
Shuangnian Xu
Xi Li
Jianmin Zhang
Jieping Chen
Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1859 - 1870
[26] Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients
Aref, Salah
Azmy, Emad
El-Bakry, Kadry
Ibrahim, Lobna
Mabed, Mohamed
HEMATOLOGY, 2018, 23 (05) : 263 - 270
[27] Malignant lymphomas of the nasal cavity and nasopharynx: Clinicopathologic study of 113 cases, identifying CD56 expression as an unfavorable prognostic factor.
Chan, JKC
Cheung, MMC
Ng, CS
Fu, WWL
Lau, WH
LABORATORY INVESTIGATION, 1997, 76 (01) : 707 - 707
[28] CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia (APL) treated with simultaneous all-trans retinoic acid (ATRA) and chemotherapy.
Ferrara, F
Morabito, F
Martino, B
Specchia, G
Liso, V
Boccuni, P
Di Noto, R
Pane, F
Annunziata, M
Schiavone, EM
Guglielmi, C
Del Vecchio, L
Lo Coco, F
BLOOD, 1999, 94 (10) : 696A - 696A
[29] The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia
Vinh Thanh Tran
Thang Thanh Phan
Hong-Phuoc Mac
Tung Thanh Tran
Toan Trong Ho
Suong Phuoc Pho
Van-Anh Ngoc Nguyen
Truc-My Vo
Hue Thi Nguyen
Thao Thi Le
Tin Huu Vo
Son Truong Nguyen
BMC Research Notes, 13
[30] The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia
Vinh Thanh Tran
Thang Thanh Phan
Hong-Phuoc Mac
Tung Thanh Tran
Toan Trong Ho
Suong Phuoc Pho
Van-Anh Ngoc Nguyen
Truc-My Vo
Hue Thi Nguyen
Thao Thi Le
Tin Huu Vo
Son Truong Nguyen
BMC RESEARCH NOTES, 2020, 13 (01)

← 1 2 3 4 5 →